UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Electrophoresis, ISSN 0173-0835, 08/2017, Volume 38, Issue 15, pp. 1932 - 1938
CEC | Sulfoxides | Fast enantioseparation | Chiral | Nano‐LC | Nano-LC | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Sulfoxides - chemistry | Models, Chemical | Time Factors | Nanotechnology - methods | Stereoisomerism | Sulfoxides - analysis | Sulfoxides - isolation & purification | Capillary Electrochromatography - methods | Chromatography, Liquid - methods | Enantiomers | Analysis | Liquid chromatography | Separation | Barriers | Scientific apparatus & instruments | Electrochromatography | Index Medicus
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 04/2015, Volume 54, Issue 17, pp. 5026 - 5043
asymmetric synthesis | homogeneous catalysis | chiral ligands | chiral sulfoxides | transition metals | Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Alkenes - chemistry | Sulfoxides - chemistry | Metals - chemistry | Stereoisomerism | Ligands | Catalysis | Cycloaddition Reaction | Alkylation | Synthesis | Enantiomers | Organosulfur compounds | Organic compounds | Index Medicus | Descriptions | Asymmetry | Chirality | Strategy | Sulfur | Bonding
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 12/2014, Volume 53, Issue 50, pp. 13871 - 13875
CH activation | atroposelectivity | asymmetric synthesis | sulfoxides | dynamic kinetic resolution | Sulfoxides | Dynamic kinetic resolution | Asymmetric synthesis | C- H activation | Atroposelectivity | Sulfoxides - chemistry | Kinetics | Stereoisomerism | Hydrogen - chemistry | Carbon - chemistry | Index Medicus | Synthesis | Pathways | Asymmetry | Dynamics | Isomerization | Strategy | Activation | Transformations | Conversion | Organic chemistry | Chemical Sciences | Catalysis
Journal Article
Tetrahedron letters, ISSN 0040-4039, 02/2020, Volume 61, Issue 7, p. 151492
Journal Article
Clinical cancer research, ISSN 1078-0432, 06/2004, Volume 10, Issue 11, pp. 3717 - 3727
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | Models, Chemical | Area Under Curve | Dimethyl Sulfoxide - chemistry | Humans | Middle Aged | Dimethyl Sulfoxide - pharmacology | Male | Antineoplastic Agents - therapeutic use | Ruthenium - chemistry | Dose-Response Relationship, Drug | DNA Adducts | Time Factors | Antineoplastic Agents - adverse effects | Organometallic Compounds - therapeutic use | Adult | Female | Antineoplastic Agents - pharmacology | Dimethyl Sulfoxide - therapeutic use | Dimethyl Sulfoxide - adverse effects | Organometallic Compounds - adverse effects | Treatment Outcome | Maximum Tolerated Dose | Aged | Dimethyl Sulfoxide - analogs & derivatives | Organometallic Compounds - pharmacology | Index Medicus
Journal Article
Biomedical chromatography, ISSN 0269-3879, 02/2020, Volume 34, Issue 2, pp. e4721 - n/a
teneligliptin sulfoxide | LC‐MS/MS | teneligliptin | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Pharmacology & Pharmacy | Chemistry, Analytical | Science & Technology | Sulfoxides - blood | Limit of Detection | Reproducibility of Results | Thiazolidines - metabolism | Thiazolidines - pharmacokinetics | Drug Stability | Humans | Sulfoxides - pharmacokinetics | Linear Models | Pyrazoles - metabolism | Thiazolidines - blood | Sulfoxides - chemistry | Pyrazoles - chemistry | Pyrazoles - blood | Sulfoxides - metabolism | Chromatography, Liquid - methods | Pyrazoles - pharmacokinetics | Tandem Mass Spectrometry - methods | Thiazolidines - chemistry | Index Medicus
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 10/2012, Volume 11, Issue 10, pp. 2265 - 2273
Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cyclin-Dependent Kinases - metabolism | Antineoplastic Combined Chemotherapy Protocols - chemistry | Humans | Sulfoxides - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Agents - administration & dosage | Pyrimidines - chemistry | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Sulfoxides - administration & dosage | Protein Kinase Inhibitors - chemistry | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cyclin-Dependent Kinases - antagonists & inhibitors | Phosphorylation - drug effects | Protein Kinase Inhibitors - pharmacokinetics | Sulfoxides - pharmacology | Administration, Oral | Pyrimidines - administration & dosage | Retinoblastoma Protein - metabolism | Etoposide - pharmacology | Rats | Treatment Outcome | Cisplatin - pharmacology | Pyrimidines - pharmacology | Antineoplastic Agents - chemistry | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Sulfoxides - chemistry | Animals | Mice, Nude | Pyrimidines - pharmacokinetics | Mice | Protein Kinase Inhibitors - pharmacology | Cell Cycle - drug effects | Index Medicus
Journal Article
Investigational new drugs, ISSN 0167-6997, 2015, Volume 33, Issue 1, pp. 201 - 214
NAMI-A | Ruthenium | Phase I | Medicine & Public Health | Gemcitabine | Non-small cell lung cancer | Oncology | Phase II | Pharmacology/Toxicology | Clinical study | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ruthenium - administration & dosage | Deoxycytidine - pharmacokinetics | Ruthenium - adverse effects | Adult | Deoxycytidine - adverse effects | Dimethyl Sulfoxide - administration & dosage | Female | Ruthenium - blood | Dimethyl Sulfoxide - adverse effects | Organometallic Compounds - adverse effects | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - metabolism | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Ruthenium - pharmacokinetics | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Dimethyl Sulfoxide - analogs & derivatives | Deoxycytidine - analogs & derivatives | Dimethyl Sulfoxide - pharmacokinetics | Organometallic Compounds - administration & dosage | Complications and side effects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Studies | Clinical trials | Lung cancer | Pharmaceutical sciences | Clinical outcomes | Index Medicus
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 07/2018, Volume 57, Issue 31, pp. 9849 - 9852
Journal Article
Journal of Chromatography A, ISSN 0021-9673, 05/2017, Volume 1499, pp. 174 - 182
Sulfoxides | Molecular modelling | Enantiomer separation | Polysaccharide-based chiral stationary phase | Conformation | Supercritical fluid chromatography | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Chromatography, Supercritical Fluid - methods | Sulfoxides - chemistry | Carbon Dioxide - chemistry | Stereoisomerism | Chromatography, Supercritical Fluid - instrumentation | Halogenation | Polysaccharides - chemistry | Sulfoxides - isolation & purification | Methanol - chemistry | Polysaccharides | Organosulfur compounds | Chromatography | Enantiomers | Analysis
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 5/2010, Volume 66, Issue 1, pp. 1 - 9
NAMI-A | Chemotherapy | Ruthenium | Medicine & Public Health | KP1019 | ONCO4417 | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Dimethyl Sulfoxide - therapeutic use | Drugs, Investigational - pharmacology | Indazoles - chemistry | Dimethyl Sulfoxide - chemistry | Humans | Dimethyl Sulfoxide - pharmacology | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Antineoplastic Agents - chemistry | Ruthenium Compounds - chemistry | Indazoles - pharmacology | Animals | Neoplasm Metastasis - drug therapy | Organometallic Compounds - therapeutic use | Organometallic Compounds - chemistry | Antineoplastic Agents - pharmacology | Dimethyl Sulfoxide - analogs & derivatives | Ruthenium Compounds - therapeutic use | Indazoles - therapeutic use | Organometallic Compounds - pharmacology | Drug Screening Assays, Antitumor | Ruthenium Compounds - pharmacology | Oncology, Experimental | Chemical properties | Metastasis | Research | Cancer | Index Medicus
Journal Article